Comparative Safety Profiles of Bevacizumab, Ranibizumab and Pegaptanib in the Treatment of Age-Related Macular Degeneration: the Analysis of the WHO Database of Adverse Drug Reactions

被引：0
|
作者：
Biagi, Chiara [1 ]
Conti, Valentino [2 ]
Bonisolli, Marta [1 ]
Melis, Mauro [1 ]
Buccellato, Elena [1 ]
Covezzoli, Anna [3 ]
Amato, Roberta [3 ]
Pazzi, Linda [3 ]
Venegoni, Mauro [2 ]
Vaccheri, Alberto [1 ]
Motola, Domenico [1 ]
机构：
[1] Univ Bologna, Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy
[2] Reg Ctr Pharmacovigilance, Milan, Lombardy Region, Italy
[3] CINECA, Interuniv Consortium, Hlth Care Syst Dept, Bologna, Italy
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
522
引用
收藏
页码：276 / 276
页数：1
相关论文
共 50 条
  • [21] Comparative Effectiveness of Bevacizumab and Ranibizumab in the Comparison of Age-Related Macular Degeneration Treatments Trials
    Messori, Andrea
    JAMA OPHTHALMOLOGY, 2015, 133 (03) : 363 - 364
  • [22] Clinical safety of ranibizumab in age-related macular degeneration
    Schmidt-Erfurth, Ursula
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 149 - 165
  • [23] Pegaptanib sodium for the treatment of neovascular age-related macular degeneration
    Moshfeghi, AA
    Puliafito, CA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (05) : 671 - 682
  • [24] Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
    Schmid, Martin K.
    Bachmann, Lucas M.
    Faes, Livia
    Kessels, Alfons G.
    Job, Oliver M.
    Thiel, Michael A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (02) : 141 - 146
  • [25] Pegaptanib Sodium in the Treatment of Neovascular Age-Related Macular Degeneration
    Querques, Giuseppe
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 225 - 234
  • [26] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07) : 1399 - 1411
  • [27] Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration
    Roller, Aaron Brock
    Amaro, Miguel Hage
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2009, 72 (05) : 677 - 681
  • [28] Comparison of Intravitreal Aflibercept with Bevacizumab and Ranibizumab for the Treatment of Wet Age-related Macular Degeneration
    Shaikh, Adeel
    Miller, Daniel
    Petersen, Michael
    Foster, Robert
    Riemann, Christopher
    Sisk, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [29] COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Stepien, Kimberly E.
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Shi, Wei
    Al-Attar, Luma
    Dubovy, Sander R.
    Murray, Timothy G.
    Davis, Janet L.
    Lee, Wen-Hsiang
    Schwartz, Stephen G.
    Smiddy, William E.
    Berrocal, Audina M.
    Flynn, Harry W., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1067 - 1073
  • [30] Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
    Javier Hernandez-Pastor, Luis
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 248 (04) : 467 - 476
12345